340 filings
Page 4 of 17
8-K
85rupf f5xu80qhyit
4 May 22
Zymeworks Provides Corporate Update and Reports First Quarter 2022 Financial Results
4:18pm
8-K/A
zs6z o50fe93
2 May 22
Cost Associated with Exit or Disposal Activities
4:29pm
8-K
cp6i mvdmc1
2 May 22
Zymeworks Announces Participation in Upcoming Investor Conferences
4:16pm
8-K
f771dn
29 Apr 22
Regulation FD Disclosure
12:00am
8-K
ywvcr7fv rw
28 Apr 22
Zymeworks Reports Last Patient Enrolled in Pivotal Study of Zanidatamab in Treatment
4:17pm
8-K
tka9uxc0t4 9fmfm
27 Apr 22
Zymeworks Announces Presentations at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
4:31pm
8-K
io8czbl7d yp
19 Apr 22
Zymeworks to Host First Quarter 2022 Results Conference Call
4:32pm
8-K
31pvpi 3n017kcor2e97
1 Apr 22
Zymeworks Announces Participation in Upcoming Investor Conferences
4:17pm
8-K
frr bjrcwg
9 Mar 22
Departure of Directors or Certain Officers
4:22pm
8-K
5iqgorrgw
3 Mar 22
Zymeworks Announces Participation in Upcoming Investor Conferences
4:16pm
S-8
4byo67bz750g 8aun
25 Feb 22
Registration of securities for employees
4:48pm
S-8
cqp3bg5p52b2 gf0omk
25 Feb 22
Registration of securities for employees
4:45pm
8-K
6ce3yq63x390psif
25 Feb 22
Material Change Report
4:20pm
8-K
y343r3vkkuqf7zv6zz1c
24 Feb 22
Zymeworks Provides Corporate Update and Reports Year-End 2021 Financial Results
12:00am
8-K
6aa 6ha14k
8 Feb 22
Zymeworks to Host Fourth Quarter and Full Year 2021 Results Conference Call
4:31pm
8-K
73im0l9h
3 Feb 22
Zymeworks Announces Participation in Upcoming Investor Conferences
4:31pm
8-K
x66l9gw4gny45
31 Jan 22
Zymeworks Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
4:25pm